NCT05488483Active, not recruiting
A Study of Tumor Imaging With Multispectral Optoacoustic Tomography
A Feasibility Study of Multispectral Optoacoustic Tomography (MSOT) Imaging in Patients With Tumors
Source: ClinicalTrials.gov · Last updated 22 Oct 2026
Brief summary (registry, in English)
Participants in this study will have Multispectral Optoacoustic Tomography/MSOT imaging of both breasts immediately before their ultrasound-guided breast biopsy procedure begins. After the MSO imaging is completed, participation in the study will end.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 12 (actual)
- First submitted
- 2 Aug 2022
- Start date
- 27 Jul 2022
- Primary completion date
- 27 Jul 2027
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Diseases
- Melanoma
- NCT number
- NCT05488483
What you commit to
- Study type: Observational
- Participants enrolled: 12
- From 27 Jul 2022 to the primary completion date, 27 Jul 2027
- 4 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Life expectancy \< 3 months
Who the study is looking for
- Participant is a female or male who is 18 years of age or older.
- Participant must meet one of the following:
- Suspicious breast imaging finding detected on either mammography, ultrasound, or MRI that is visible on ultrasound and therefore recommended for ultrasound-guided breast biopsy (BI-RADS 4 suspicious abnormality; BI-RADS 5, highly suggestive for malignancy)
- No previous treatment for breast cancer
- Diagnosis of melanoma
Age in the registry: 18 years to - · Sex: Female · Accepts healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Helmholtz Institute (Data Analysis Only) Coordinator of this site? Confirm its status | Munich | Germany | Unknown status |
| Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent only) Coordinator of this site? Confirm its status | Commack | United States | Unknown status |
| Memorial Sloan Kettering Bergen (Consent Only) Coordinator of this site? Confirm its status | Montvale | United States | Unknown status |
| Memorial Sloan-Kettering Cancer Center Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.